Voloridge Investment Management
BCYC

Voloridge Investment Management’s Bicycle Therapeutics BCYC Stock Holding History

Voloridge Investment Management’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-62,667
Closed -$1.46M – 1429
2022
Q3 		$1.46M Sell
62,667
-60,383
-49% -$1.44M 0.01% 1070
2022
Q2 		$2.06M Buy
+123,050
New +$2.59M 0.01% 1008
2022
Q1 		– Sell
-52,575
Closed -$3.2M – 1370
2021
Q4 		$3.2M Buy
+52,575
New +$2.9M 0.02% 897

Other funds holding BCYC

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
RCI
Ridgeback Capital Investments Miami Beach, Florida $560K AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return

Voloridge Investment Management's BCYC Position: Q4 2022 in Review

Voloridge Investment Management sold out of Bicycle Therapeutics (BCYC) in Q4 2022, closing a stake of 62,667 shares — an estimated $1.46M sold.

Voloridge Investment Management first reported a position in BCYC in Q4 2021 and held it in 3 quarters. The position peaked at $3.2M in Q4 2021. 87 funds tracked by Wall St. Rank hold BCYC as of Q4 2022.

  • Voloridge Investment Management reported no remaining Bicycle Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Voloridge Investment Management sold 62,667 Bicycle Therapeutics shares in Q4 2022, an estimated $1.46M.
  • Voloridge Investment Management first reported a position in Bicycle Therapeutics in Q4 2021 and held it in 3 quarters.
  • Voloridge Investment Management's Bicycle Therapeutics position peaked at $3.2M in Q4 2021.
  • 87 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q4 2022.

Based on Voloridge Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.